Cargando…

Germline TP53 mutations in Finnish breast cancer patients

Detalles Bibliográficos
Autores principales:	Rapakko, K, Allinen, M, Syrjäkoski, K, Vahteristo, P, Huusko, P, Vähäkangas, K, Eerola, H, Kainu, T, Kallioniemi, O-P, Nevanlinna, H, Winqvist, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300899/ http://dx.doi.org/10.1186/bcr98

Ejemplares similares

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
por: Rapakko, K, et al.
Publicado: (2001)

Mutation analysis of the CHK2 gene in families with hereditary breast cancer
por: Allinen, M, et al.
Publicado: (2001)

Inherited and de novo germline TP53 mutations in adult-onset sarcoma
por: Thomas, David M, et al.
Publicado: (2012)

Inherited and de novo germline TP53 mutations in adult-onset sarcoma
por: Thomas, DM, et al.
Publicado: (2012)

Pathogenic germline TP53 mutations in adult sarcoma patients; implications for treatment and screening – description of an upcoming project
por: Mahendran, K, et al.
Publicado: (2012)

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Germline mutation in the TP53 gene in uveal melanoma
por: Hajkova, Nikola, et al.
Publicado: (2018)

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
por: Vahteristo, P, et al.
Publicado: (2001)

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
por: Kwong, Ava, et al.
Publicado: (2020)

Number of rare germline CNVs and TP53 mutation types
por: Silva, Amanda G, et al.
Publicado: (2012)

Clinical implications of germline mutations in breast cancer: TP53
por: Schon, Katherine, et al.
Publicado: (2017)

Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015)

Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome
por: Li, Yanong, et al.
Publicado: (2021)

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
por: Peltonen, Jenni K, et al.
Publicado: (2011)

DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations
por: Fortes, F.P., et al.
Publicado: (2015)

Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network
por: Pylkäs, Katri, et al.
Publicado: (2012)

Modeling the prevalent germline TP53 R337H mutation in mouse
por: Park, Ji-Hoon, et al.
Publicado: (2019)

Emerging insights into ethnic-specific TP53 germline variants
por: Fischer, Nicholas W, et al.
Publicado: (2023)

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
por: Assumpção, Juliana G, et al.
Publicado: (2011)

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
por: Assumpção, Juliana G, et al.
Publicado: (2008)

A Mouse Homolog of a Human TP53 Germline Mutation Reveals a Lipolytic Activity of p53
por: Kang, Ju-Gyeong, et al.
Publicado: (2020)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2016)

Comparing ion torrent with pyrosequencing and Sanger sequencing for the detection of TP53 mutations in colorectal cancer
por: Doyle, Brendan, et al.
Publicado: (2014)

Epidermal Growth Factor Receptor-mutated Lung Cancer as the Initial Manifestation of Germline TP53 Mutation Associated Cancer
por: Pathak, Surabhi, et al.
Publicado: (2018)

Somatic TP53 variants frequently confound germline testing results
por: Weitzel, Jeffrey N., et al.
Publicado: (2017)

Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020)

LFSPROShiny: an interactive R/Shiny app for prediction and visualization of cancer risks in families with deleterious germline TP53 mutations
por: Nguyen, Nam H, et al.
Publicado: (2023)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
por: Mäkinen, Netta, et al.
Publicado: (2016)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

Increased Oxidative Damage in Carriers of the Germline TP53 p.R337H Mutation
por: Macedo, Gabriel S., et al.
Publicado: (2012)

High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort
por: Mitchell, Gillian, et al.
Publicado: (2013)

Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark
por: Stoltze, Ulrik, et al.
Publicado: (2018)

Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
por: Alyami, Hassan, et al.
Publicado: (2021)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
por: Kai, Masaya, et al.
Publicado: (2022)

Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
por: Light, Nicholas, et al.
Publicado: (2023)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_d0f172ev9jihubs0mtsbcs574d